Current Issue: Volume 03, Issue 03

Impact of No-Code AI Drug Discovery Platforms on the Operational Cost Structure of Biotechnology Ventures
Timotej Szalay
View PDF Full Text doi https://doi.org/10.70315/uloap.ulbec.2026.0303001